Park Ha Biological Technology Co., Ltd. (NASDAQ:BYAH)
| Market Cap | $635.79K-99.2% |
| Revenue (ttm) | $3.82M+32.0% |
| Net Income | -$8.17M+51.7% |
| EPS | -$10.92+77.5% |
| Shares Out | 747.90K |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 55,163 |
| Open | $1.12 |
| Previous Close | $1.04 |
| Day's Range | $0.85 - $1.12 |
| 52-Week Range | $0.85 - $112.00 |
| Beta | 0.20 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About BYAH
This enterprise functions as an investment holding company, with its core business centered on crafting and distributing skincare solutions. Operating under the "Park Ha" brand, these products are sold across the People's Republic of China. The company executes these activities through its affiliated subsidiaries, which manage both direct product sales and the provision of franchise services.
$BYAH stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in BYAH holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by BYAH's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
BYAH Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New BYAH patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to BYAH from public contracts
Source: USAspending.gov
Bull Case vs Bear Case
AI-generated from BYAH’s recent data — informational, not investment advice
